Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society

Identifieur interne : 002B50 ( Main/Curation ); précédent : 002B49; suivant : 002B51

Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society

Auteurs : Christine M. Vatovec ; Mujde Z. Erten ; Jane Kolodinsky ; Phil Brown ; Marie Wood ; Ted James ; Brian L. Sprague

Source :

RBID : PMC:4372113

Abstract

Nearly 20% of all breast cancer cases are ductal carcinoma in situ (DCIS), with over 60,000 cases diagnosed each year. Many of these cases would never cause clinical symptoms or threaten the life of the woman; however, it is currently impossible to distinguish which lesions will progress to invasive disease from those that will not. DCIS is generally associated with an excellent prognosis regardless of treatment pathway, but there is variation in treatment aggressiveness that appears to exceed the medical uncertainty associated with DCIS management. Therefore, it would seem that a significant proportion of women with DCIS receive more extensive treatment than is needed. This overtreatment of DCIS is a growing concern among the breast cancer community and has implications for both the patient (via adverse treatment-related effects, as well as out-of-pocket costs) and society (via economic costs and the public health and environmental harms resulting from healthcare delivery). This paper discusses DCIS treatment pathways and their implications for patients and society, and calls for further research to examine the factors that are leading to such wide variation in treatment decisions.


Url:
PubMed: 25403959
PubMed Central: 4372113

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:4372113

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society</title>
<author>
<name sortKey="Vatovec, Christine M" sort="Vatovec, Christine M" uniqKey="Vatovec C" first="Christine M." last="Vatovec">Christine M. Vatovec</name>
</author>
<author>
<name sortKey="Erten, Mujde Z" sort="Erten, Mujde Z" uniqKey="Erten M" first="Mujde Z." last="Erten">Mujde Z. Erten</name>
</author>
<author>
<name sortKey="Kolodinsky, Jane" sort="Kolodinsky, Jane" uniqKey="Kolodinsky J" first="Jane" last="Kolodinsky">Jane Kolodinsky</name>
</author>
<author>
<name sortKey="Brown, Phil" sort="Brown, Phil" uniqKey="Brown P" first="Phil" last="Brown">Phil Brown</name>
</author>
<author>
<name sortKey="Wood, Marie" sort="Wood, Marie" uniqKey="Wood M" first="Marie" last="Wood">Marie Wood</name>
</author>
<author>
<name sortKey="James, Ted" sort="James, Ted" uniqKey="James T" first="Ted" last="James">Ted James</name>
</author>
<author>
<name sortKey="Sprague, Brian L" sort="Sprague, Brian L" uniqKey="Sprague B" first="Brian L." last="Sprague">Brian L. Sprague</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25403959</idno>
<idno type="pmc">4372113</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372113</idno>
<idno type="RBID">PMC:4372113</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">003876</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003876</idno>
<idno type="wicri:Area/Pmc/Curation">003875</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003875</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001C09</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001C09</idno>
<idno type="wicri:Area/Ncbi/Merge">006D20</idno>
<idno type="wicri:Area/Ncbi/Curation">006D20</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">006D20</idno>
<idno type="wicri:doubleKey">1045-4403:2014:Vatovec C:ductal:carcinoma:in</idno>
<idno type="wicri:Area/Main/Merge">002B54</idno>
<idno type="wicri:Area/Main/Curation">002B50</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society</title>
<author>
<name sortKey="Vatovec, Christine M" sort="Vatovec, Christine M" uniqKey="Vatovec C" first="Christine M." last="Vatovec">Christine M. Vatovec</name>
</author>
<author>
<name sortKey="Erten, Mujde Z" sort="Erten, Mujde Z" uniqKey="Erten M" first="Mujde Z." last="Erten">Mujde Z. Erten</name>
</author>
<author>
<name sortKey="Kolodinsky, Jane" sort="Kolodinsky, Jane" uniqKey="Kolodinsky J" first="Jane" last="Kolodinsky">Jane Kolodinsky</name>
</author>
<author>
<name sortKey="Brown, Phil" sort="Brown, Phil" uniqKey="Brown P" first="Phil" last="Brown">Phil Brown</name>
</author>
<author>
<name sortKey="Wood, Marie" sort="Wood, Marie" uniqKey="Wood M" first="Marie" last="Wood">Marie Wood</name>
</author>
<author>
<name sortKey="James, Ted" sort="James, Ted" uniqKey="James T" first="Ted" last="James">Ted James</name>
</author>
<author>
<name sortKey="Sprague, Brian L" sort="Sprague, Brian L" uniqKey="Sprague B" first="Brian L." last="Sprague">Brian L. Sprague</name>
</author>
</analytic>
<series>
<title level="j">Critical reviews in eukaryotic gene expression</title>
<idno type="ISSN">1045-4403</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">Nearly 20% of all breast cancer cases are ductal carcinoma in situ (DCIS), with over 60,000 cases diagnosed each year. Many of these cases would never cause clinical symptoms or threaten the life of the woman; however, it is currently impossible to distinguish which lesions will progress to invasive disease from those that will not. DCIS is generally associated with an excellent prognosis regardless of treatment pathway, but there is variation in treatment aggressiveness that appears to exceed the medical uncertainty associated with DCIS management. Therefore, it would seem that a significant proportion of women with DCIS receive more extensive treatment than is needed. This overtreatment of DCIS is a growing concern among the breast cancer community and has implications for both the patient (via adverse treatment-related effects, as well as out-of-pocket costs) and society (via economic costs and the public health and environmental harms resulting from healthcare delivery). This paper discusses DCIS treatment pathways and their implications for patients and society, and calls for further research to examine the factors that are leading to such wide variation in treatment decisions.</p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B50 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002B50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:4372113
   |texte=   Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:25403959" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024